Acidophil is an innovation company that uses technical and business information together with bio-chemical capabilities to create, manage and co-finance new products and biotechnology businesses in human health, agriculture, and animal health. With operations in both the United States (Lutherville, MD) and United Kingdom (Cambridge), Acidophil takes a global approach to innovation, management and investment that reflects the international perspective of its team and founders. Acidophil exploits a virtual business development model to enable capital efficient innovation in collaboration with scientists, entrepreneurs, corporations and investors who are interested in addressing global market needs.